Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Blue Turtle Bio Technologies, Inc logo — company profile

Blue Turtle Bio Technologies, Inc

Founded 2014 1 employees Convertible Note Total: $100.00K Biotechnology, Health Care +1

General Information

Company Name Blue Turtle Bio Technologies, Inc
Founded Year 2014
Employees 1
Industries Biotechnology, Health Care, Privacy and Security
Funding Stage Convertible Note
Social

BounceWatch is an independent company data service, not affiliated with Blue Turtle Bio Technologies, Inc. To contact Blue Turtle Bio Technologies, Inc, visit blueturtlebio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Blue Turtle Bio Technologies, Inc

BlueTurtleBio Technologies, founded in 2014, is a biotechnology startup with a focused mission on the golden triangle of healthcare: safety, effectiveness, and accessibility. The company aims to address the shortcomings in most healthcare options by leveraging the genetically malleable and easily replenishable organ in the human body - the microbiome. This innovative approach sets them apart in the Biotechnology and Health Care industries. Their last investment, a Convertible Note investment, took place on 23 August 2016, with SOSV as the investor. BlueTurtleBio Technologies' unique focus on leveraging the microbiome for healthcare solutions presents an intriguing opportunity for venture capital firms looking to invest in groundbreaking biotech innovations.

Taxonomy: microbiome therapeutics, genetic engineering, pharmaceuticals, rare diseases, drug delivery, medical innovation, patient safety, effectiveness, affordability, next generation therapies

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Convertible Note Undisclosed 1
SOSV
SOSV
23 Aug 2016
Pre Seed Round $100.00K 2
SOSV indiebio
SOSV, indiebio
23 Feb 2015

Blue Turtle Bio Technologies, Inc Alternatives & Competitors

View All Alternatives
Blue Turtle Bio Technologies, Inc vs
Cerium Pharmaceuticals
Cerium Pharmaceuticals

Rare people. Rare Medicines.

Venture round
4 employees
Biotechnology, Health Care
Blue Turtle Bio Technologies, Inc vs
Quellis Biosciences
Quellis Biosciences

Committed to enhancing patient lives with advanced antibody treatments for rare diseases.

Series A
Biotechnology, Health Care
Blue Turtle Bio Technologies, Inc vs
Ultragenyx
Ultragenyx United States

Going Beyond Every Day

Post-IPO Equity
1535 employees
Biotechnology, Health Care
View all alternatives

FAQ About Blue Turtle Bio Technologies, Inc

Our mission is the golden triangle of healthcare: safety, effectiveness and accessibility. Most healthcare options miss one or more of these standards. At Blue Turtle, we plan to recruit a genetically malleable and easily replenishable organ in the human body: the microbiome, to help carry out this...
Blue Turtle Bio Technologies, Inc was founded in 2014.
Blue Turtle Bio Technologies, Inc operates in Biotechnology, Health Care and Privacy and Security. Its work centres on microbiome therapeutics, genetic engineering, pharmaceuticals and rare diseases.
Blue Turtle Bio Technologies, Inc has approximately 1 employees.
Blue Turtle Bio Technologies, Inc has completed 2 funding rounds, raising a total of $100.00K. The latest funding stage is Convertible Note.
Top alternatives and competitors to Blue Turtle Bio Technologies, Inc include Cerium Pharmaceuticals, Quellis Biosciences, Ultragenyx, Astria Therapeutics, Inc., Dicerna Pharmaceuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Blue Turtle Bio Technologies, Inc and Cerium Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Blue Turtle Bio Technologies, Inc, https://bouncewatch.com/company/blueturtlebio-technologies, updated 14 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes